Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Enhancing Innate Immune Activation |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2008-01-18 |
| Study Made Public: | 2011-02-25 |
Title
Ho_Verhagen_Clade_C_V3_Peptides
Description
CAVD 292 is a preclinical rabbit study to evaluate neutralization activity of Clade C consensus C3 and V4 peptide/adjuvant prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
CFA IFA Clade C V3 peptideIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.